SP1 and neoplasm: Furthermore, butyrate can activate Tyrosine Phosphatase to dephosphorylate Sp1, which inhibits the binding of Sp1 to the VEGF promoter, and leads to reduced VEGF expression and angiogenesis, subsequently diminishing tumor metastasis (Prasanna Kumar et al. 2008).